E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers P > Headlines for Progenics Pharmaceuticals Inc. > News item
Published on 6/19/2013 in the Prospect News PIPE Daily.

Progenics Pharmaceuticals intends to price public sale of common stock

Bookrunner Jefferies raises proceeds for research and development

By Devika Patel

Knoxville, Tenn., June 19 - Progenics Pharmaceuticals Inc. said it will price a public offering of common shares. The deal will have a 30-day greenshoe.

Jefferies LLC is the bookrunning manager.

Proceeds will be used for research and development and general corporate purposes.

Progenics, based in Tarrytown, N.Y., is a biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.